Recherche Fr menu fr ClientConnect
Recherche
Résultats
5 premiers résultats de la recherche Voir tous les résultats Recherche avancée
Recherches les plus fréquentes
Pages les plus visitées
    Référence: 20210757
    Date de publication: 2 février 2023

    Promoteur – Intermédiaire Financier

    COMPUGROUP MEDICAL SE & CO KGAA

    Lieu

    Description

    The project will finance the promoter's expenditures in Research, Development and Innovation (RDI) targeting healthcare system digitalisation. In particular, investments concern software for digitalisation in medical care, individual health management and interoperability aimed at improving the user experience and developing state-of-the-art technologies in the field, including improving cyber-security for medical data.

    Additionality and Impact

    The project concerns digital health. Digital health is a broad concept that includes solutions for telemedicine and teleconsultation, remote monitoring, connected devices, digital health platforms and health apps. The concept also covers the related health data analysis and application in systems based on big data, for instance for epidemiological research and AI-enabled diagnosis support. The current project will develop solutions related but not limited to telemedicine and teleconsultation, and digital health platforms for the management of hospitals and medical practices with a significant socio-economic impact. Digitisation is crucial to EU's competitiveness, where EU is aiming to catch-up with other regions of the World. This Project would further aid to accelerate adoption of digital technologies in the EU, related to healthcare and digital innovation. As such, through the financing of this Project aiming to facilitate increased investments in digital innovation the EIB is helping to bridge the digital gap between EU and US, e.g., and the digital divide within EU. 


    Objectifs

    This RDI project would lead to improved cost savings and effectiveness in medical diagnosis and treatment and, as such, address an unmet medical need in a growing population, while preserving and cultivating highly skilled jobs.

    Secteur(s)

    • Santé - Santé humaine et action sociale

    Montant BEI envisagé (montant approximatif)

    EUR 200 million

    Coût total (montant approximatif)

    EUR 450 million

    Aspects environnementaux

    The RDI activities are expected to be carried out in existing facilities that are already used for the same purposes and that are not expected to change their scope due to the project. An Environmental Impact Assessment (EIA) is therefore not needed as per EIA Directive 2014/52/EU, amending Directive 2011/92/EU. This aspect will be further assessed during the project appraisal.

    Passation des marchés

    The promoter has been assessed by the EIB as being a private company not being subject to EU public procurement rules or concessions. However, if at the project appraisal, the EIB were to conclude that the promoter is subject to the EU public procurement legislation then the European Commission will be informed accordingly and the promoter will be required to apply those rules.

    Statut

    Signé - 22/06/2022

    Milestone
    À l'examen
    Approuvé
    Signé
    25 mai 2022
    22 juin 2022

    Clause de non-responsabilité

    Avant d’être approuvés par le Conseil d’administration et avant la signature des prêts correspondants, les projets font l’objet d’une instruction et de négociations. Par conséquent, les informations et données fournies sur cette page sont indicatives.
    Elles sont fournies à des fins de transparence uniquement et ne peuvent être considérées comme représentant la politique officielle de la BEI (voir également les notes explicatives).

    Mots-clés correspondants

    Allemagne Pays de l’UE Autriche Roumanie Suède Italie Santé